REFRACTORY LEUKEMIA

Clinical trials for REFRACTORY LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Scientists test new weapon in fight against tough blood cancer

Disease control Not yet recruiting

This early-stage study aims to find a safe dose for a new three-drug combination to treat acute myeloid leukemia (AML). Researchers will add an experimental drug called eganelisib to two standard medications to see if it's safe and shows early signs of helping patients. The study…

Matched conditions: REFRACTORY LEUKEMIA

Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

REFRACTORY LEUKEMIA

Get alerted when new REFRACTORY LEUKEMIA trials appear

Scientists test new weapon in fight against tough blood cancer